ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,455, issued on April 21, was assigned to Vascular Biosciences (San Diego).
"CAR peptide for improved coronavirus survival" was invented by David Mann (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "A conjugate for treating an individual suffering from a disease, wherein the conjugate is comprised of: a targeting peptide comprising a sequence substantially identical to CAR, or a variant thereof; and at least one therapeutic molecule and methods for making and administering same. Also disclosed is a combination product for use in the treatment of a disease, wherein the combination product comprises: (a) a targeting peptide comprising a sequ...